Inactive Instrument
Integrative Health Technologies, Inc. Stock Other OTC
Stocks
IHTI
US45822A2078
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 402K 353K 333K 304K 569K 38.57M 573K 3.99M 1.55M 19.7M 1.51M 1.48M 63.32M | P/E 2008 |
231x | P/E 2009 | 31.6x |
|---|---|---|---|---|---|
| Enterprise Value | 497K 436K 412K 375K 702K 47.6M 707K 4.93M 1.91M 24.32M 1.86M 1.82M 78.16M | EV / Sales 2008 |
14,379,727x | EV / Sales 2009 | 2,939,517x |
| Free-Float |
48.33% | Yield 2008 * |
-
| Yield 2009 | - |
| 1 day | +78.31% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilbert R. Kaats
CEO | Chief Executive Officer | - | - |
Samuel C. Keith
CIO | Chief Investment Officer | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +78.31% | +78.31% | - | - | 40 | |
| -0.14% | +4.33% | +9.88% | +31.73% | 48.01B | |
| -1.69% | +1.48% | +53.02% | +33.59% | 45.27B | |
| +2.56% | +7.34% | +382.17% | +594.81% | 42.84B | |
| +0.24% | +2.85% | +9.78% | +89.54% | 40.93B | |
| -0.62% | -1.11% | +4.70% | +46.02% | 29.6B | |
| -0.28% | +1.07% | +26.83% | +152.91% | 17.32B | |
| -0.46% | +1.20% | +26.78% | +41.32% | 15.34B | |
| -2.21% | -4.70% | - | - | 15.15B | |
| +3.37% | +9.21% | +9.93% | - | 14.84B | |
| Average | +7.91% | +1.60% | +65.39% | +141.42% | 29.92B | |
| Weighted average by Cap. | +0.08% | +1.77% | +81.87% | +153.92% |
| 2008 | 2009 | |
|---|---|---|
| Net sales | 0.43 0.38 0.36 0.33 0.61 41.36 0.61 4.28 1.66 21.13 1.62 1.59 67.9 | 0.45 0.39 0.37 0.34 0.63 42.89 0.64 4.44 1.72 21.91 1.68 1.64 70.42 |
| Net income | 26.48K 23.24K 21.95K 20K 37.44K 2.54M 37.71K 263K 102K 1.3M 99.44K 97.29K 4.17M | 38.69K 33.95K 32.06K 29.22K 54.7K 3.71M 55.09K 384K 149K 1.89M 145K 142K 6.09M |
| Net Debt | 99.02K 86.89K 82.07K 74.79K 140K 9.49M 141K 982K 380K 4.85M 372K 364K 15.58M | 94.3K 82.75K 78.15K 71.22K 133K 9.04M 134K 935K 362K 4.62M 354K 346K 14.84M |
Employees
-
